Tau proteins: New approach against Alzheimer’s in clinical trial
A novel drug to combat Alzheimer’s disease has shown good safety in a study involving more than 30 patients. The experimental…
Prof. Stefan Teipel talks about Alzheimer's and Lecanemab in health magazine "Apotheken Umschau"
The newly developed drug Lecanemab - this is the title story of the new issue of the German health…
Researchers at DZNE and the University Hospital Bonn, together with the Berlin-based company PeakProfiling GmbH, have developed a digital technology that recognizes the severity of speech…
New indicator for amyloid deposits discovered
Ulm/Halle, April 13, 2023 – Two characteristic pathologies of Alzheimer's disease are related: Deposits of amyloid beta peptide in the brain and…
Survey Underscores Interest in Exchange between Health Care Research and Practice
A survey among professionals from health care research and dementia care underlines the strong need for mutual…
